Pharmacokinetics and Metabolism Study in Healthy Male Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

July 19, 2017

Primary Completion Date

October 15, 2017

Study Completion Date

October 15, 2017

Conditions
Cancer
Interventions
DRUG

BMS-986205

Carbon 14 tagged BMS-986205

Trial Locations (1)

53704

Covance Clinical Research Unit, Inc., Madison

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT03247283 - Pharmacokinetics and Metabolism Study in Healthy Male Participants | Biotech Hunter | Biotech Hunter